SLEEP-DISORDERED BREATHING

Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation

A J Piper^1,2,3, D Wang^1,2, B J Yee^1,2,3, D J Barnes¹, R R Grunstein^1,2,3

¹ Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, Sydney, Australia
² Sleep and Circadian Group, Woolcock Institute of Medical Research, Sydney, Australia
³ NHMRC Centre for Respiratory and Sleep Medicine, University of Sydney, Camperdown, Sydney, Australia

Dr A J Piper, Respiratory Failure Service, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, Sydney, NSW 2050, Australia; ajp{at}mail.med.usyd.edu.au

Background: Untreated, obesity hypoventilation is associated with significant use of health care resources and high mortality. It remains unclear whether continuous positive airway pressure (CPAP) or bilevel ventilatory support (BVS) should be used as initial management. The aim of this study was to determine if one form of positive pressure is superior to the other in improving daytime respiratory failure.

Methods: A prospective randomised study was performed in patients with obesity hypoventilation referred with respiratory failure. After exclusion of patients with persisting severe nocturnal hypoxaemia (SpO₂ <80% for >10 min) or carbon dioxide retention (>10 mm Hg) despite optimal CPAP, the remaining patients were randomly assigned to receive either CPAP or BVS over a 3-month period. The primary outcome was change in daytime carbon dioxide level. Secondary outcome measures included daytime sleepiness, quality of life, compliance with treatment and psychomotor vigilance testing.

Results: Thirty-six patients were randomised to either home CPAP (n = 18) or BVS (n = 18). The two groups did not differ significantly at baseline with regard to physiological or clinical characteristics. Following 3 months of treatment, daytime carbon dioxide levels decreased in both groups (CPAP 6 (8) mm Hg; BVS 7 (7) mm Hg) with no between-group differences. There was no difference in compliance between the two treatment groups (5.8 (2.4) h/night CPAP vs 6.1 (2.1) h/night BVS). Although both groups reported an improvement in daytime sleepiness, subjective sleep quality and psychomotor vigilance performance were better with BVS.

Conclusions: Both CPAP and BVS appear to be equally effective in improving daytime hypercapnia in a subgroup of patients with obesity hypoventilation syndrome without severe nocturnal hypoxaemia.

Trial registration number: Australian Clinical Trials Registry ACTRN01205000096651.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Airwaves

Wisia Wedzicha
Thorax 2008 63: 387. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Kaw, R., Hernandez, A. V., Walker, E., Aboussouan, L., Mokhlesi, B. (2009). Determinants of Hypercapnia in Obese Patients With Obstructive Sleep Apnea: A Systematic Review and Metaanalysis of Cohort Studies. Chest 136: 787-796 [Abstract] [Full Text]  
• McEvoy, R D, Pierce, R J, Hillman, D, Esterman, A, Ellis, E E, Catcheside, P G, O'Donoghue, F J, Barnes, D J, Grunstein, R R, on behalf of the Australian trial of non-invasive, (2009). Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax 64: 561-566 [Abstract] [Full Text]  
• Crummy, F, Piper, A J, Naughton, M T (2008). Obesity and the lung: 2 {middle dot} Obesity and sleep-disordered breathing. Thorax 63: 738-746 [Abstract] [Full Text]